Chat with us
Research Assistance
Online
  • Please enter your first name.

Middle East & Africa Stomach Cancer Treatment Market Size & Outlook

The stomach cancer treatment market in Middle East & Africa is expected to reach a projected revenue of US$ 344.0 million by 2030. A compound annual growth rate of 23.2% is expected of Middle East & Africa stomach cancer treatment market from 2025 to 2030.

  • Pharmaceuticals
    • Oncology Drugs
      • Stomach Cancer Treatment Market Outlook
Revenue, 2024 (US$M)
$108.8
Forecast, 2030 (US$M)
$344.0
CAGR, 2025 - 2030
23.2%
Report Coverage
Middle East & Africa

Middle East Africa Stomach Cancer Treatment Market, 2018-2030 (US$M)

Middle East Africa Stomach Cancer Treatment Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the stomach cancer treatment market

Every figure cited from GVR research

MEA stomach cancer treatment market highlights

  • The MEA stomach cancer treatment market generated a revenue of USD 108.8 million in 2024.
  • The market is expected to grow at a CAGR of 23.2% from 2025 to 2030.
  • In terms of segment, targeted therapy was the largest revenue generating treatment type in 2024.
  • Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.

MEA data book summary

Market revenue in 2024USD 108.8 million
Market revenue in 2030USD 344.0 million
Growth rate23.2% (CAGR from 2025 to 2030)
Largest segmentTargeted therapy
Fastest growing segmentImmunotherapy
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationStandard Chemotherapy, Targeted Therapy, Immunotherapy
Key market players worldwideNovartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis

Other key industry trends

  • In terms of revenue, MEA region accounted for 2.0% of the global stomach cancer treatment market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • MEA is the fastest growing regional market and is projected to reach USD 344.0 million by 2030.

No credit card required*

Publish Date: Dec 24, 2024

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Stomach Cancer Treatment Market Companies

NameProfile# EmployeesHQWebsite
Novartis AG ADRView profile 76,057Lichtstrasse 35, Basel, Switzerland, 4056www.novartis.com
Teva Pharmaceutical Industries LtdView profile 37,851124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020www.tevapharm.com
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Pfizer IncView profile 88,00066 Hudson Boulevard East, New York, NY, United States, 10001-2192www.pfizer.com
Merck & Co IncView profile 72,000126 East Lincoln Avenue, Rahway, NJ, United States, 07065www.merck.com
Bristol-Myers Squibb CoView profile 34,100Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543www.bms.com
Eli Lilly and CoView profile 43,000Lilly Corporate Center, Indianapolis, IN, United States, 46285www.lilly.com
Viatris IncView profile 38,0001000 Mylan Boulevard, Canonsburg, PA, United States, 15317www.viatris.com
Celltrion HealthcareView profile 51-100Incheon, Inch'on-jikhalsi, South Korea, Asiawww.celltrionhealthcare.com/
Samsung BioepisView profile 501-1000Incheon, Inch'on-jikhalsi, South Korea, Asiawww.samsungbioepis.com

Middle East & Africa Stomach Cancer Treatment Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Stomach Cancer Treatment Market Outlook will help companies and investors design strategic landscapes.


Targeted Therapy was the largest segment with a revenue share of 45.59% in 2024.

Horizon Databook has segmented the Middle East & Africa stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.


  • Middle East & Africa Stomach Cancer Treatment Market Treatment Type Outlook (Revenue, USD Million , 2018-2030)
    • Standard Chemotherapy
    • Targeted Therapy
    • Immunotherapy
  • Middle East & Africa Stomach Cancer Treatment Market Disease Indication Outlook (Revenue, USD Million , 2018-2030)
    • Gastric cancer/Gastroesophageal Junction cancer
    • Gastrointestinal Stromal Tumors
  • Middle East & Africa Stomach Cancer Treatment Market Route of Administration Outlook (Revenue, USD Million , 2018-2030)
    • Oral
    • Injectable
  • Middle East & Africa Stomach Cancer Treatment Market Drug Class Outlook (Revenue, USD Million , 2018-2030)
    • PD-1/PD-L1 Inhibitors
    • HER2 Antagonists
    • VEGFR Antagonists
    • Others

Reasons to subscribe to Stomach Cancer Treatment Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Stomach Cancer Treatment Market Outlook databook

  • Our clientele includes a mix of Stomach Cancer Treatment Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Stomach Cancer Treatment Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Stomach Cancer Treatment Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Middle East Africa Stomach Cancer Treatment Market, 2018-2030 (US$M)

No Access Stack Chart

MEA stomach cancer treatment market statistics, by treatment type, 2018-2030 (US$M)

No Access Pie Chart

MEA stomach cancer treatment market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more